Home LiteratureArticle Details

PMID: 8554911 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

AIDS research and human retroviruses ·Vol. 11 ·No. 9 ·1995-09-00 ·Pages 1131-3

Rencher SD, Slobod KS, Dawson DH, Lockey TD, Hurwitz JL

Abstract

暂无摘要

MeSH Terms

AIDS Vaccines/genetics,immunology Amino Acid Sequence Gene Products, env/genetics,immunology Genes, env HIV Antibodies HIV Envelope Protein gp120/genetics,immunology HIV Infections/immunology,prevention & control,virology HIV-1/genetics,immunology,isolation & purification Humans Molecular Sequence Data Neutralization Tests Peptide Fragments/genetics,immunology

Chemicals

AIDS Vaccines Gene Products, env HIV Antibodies HIV Envelope Protein gp120 HIV envelope protein gp120 (305-321) Peptide Fragments

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Rencher S D

Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Slobod K S

Dawson D H

Lockey T D

Hurwitz J L

Article Info

Journal

AIDS research and human retroviruses

Abbr.

AIDS Res Hum Retroviruses

ISSN

0889-2229

DOI

10.1089/aid.1995.11.1131

Published

1995-09-00

Pages

1131-3

Language

English

Region

United States

NLM ID

8709376

Subset

Grants

NIAID NIH HHS · P01-AI31596 · United States

NCI NIH HHS · P30-CA21765 · United States

NCI NIH HHS · R01-CA57419 · United States

Databases

GENBANK

U28283, U28284, U28285, U28286, U28287, U28288, U28289, U28290, U28291, U28292, U28293, U28313, U28314, U28315, U28316, U28317, U28318, U28319, U28320

External Links

PubMed source DOI: 10.1089/aid.1995.11.1131 View journal details

Analysis Services

Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

Contact

WeChat Official Account